Dr. Joan Montaner, is a neurologist and co-founder of the Company. He is the Director of the Neurovascular Research Laboratory at the Vall d’Hebron Research Institute (VHIR) and Vall d’Hebron Hospital in Barcelona. In recent years, his laboratory has been one of the most active groups in translational research in the field of stroke biomarkers. His activities in this laboratory and at the Stroke Unit are reflected in more than 300 published peer reviewed articles (h-index = 52). In addition, Joan is as well the Director of the Stroke Programme, IBIS-HVR-HVM, in Sevilla.
Prof. Jean-Charles Sanchez is a co-founder of the Company. He has been working since 1989 in the field of proteomics and diagnostic biomarker discovery. He obtained his Ph.D. in Biochemistry at the Buckingham University (UK) in the field of proteomics and diabetes. Since 1995, he has been the head of the Translational Biomarker Group at the Faculty of Medicine in the University of Geneva and director of the Proteomics Core Facility of the Faculty of Medicine. As a co-inventor of the proteome concept, he has soon evaluated the great impact proteomics could have in biomarker discovery. All these results permit to develop new diagnostic, therapeutic and predictive tools. In addition, he is the founder of the Swiss Proteomics Society (SPS) and the European Proteomics Association (EuPA). He is also the Editor in Chief of the journal Translational Proteomics. Jean-Charles Sanchez is as well the author or co-author of more than 200 papers (h-index= 71) in refereed journals and in 30 book chapters and 30 patents.
Dr. Alan Cookson is a co-founder of the Company. He brings substantial experience of the pharmaceutical industry both from his career in the Ares-Serono group in Europe and the United States where he held positions of increasing responsibility including VP, Research and Business Development, and as founder and CEO of three start-up companies. Alan has also specialised in encouraging and managing the commercial exploitation of academic research innovation. And he has led a number of life sciences licensing projects for the University of Geneva, including the project that inspired the formation of ABCDx.
Chantal Loze studied Biology at the University of Geneva. She holds a Master Degree in Physiology and Metabolism for which she obtained the Arditi Award in 1995 and a Master in Life Sciences Law. Then, she has joined for several years the technology transfer office of the University of Geneva for encouraging and managing the commercial exploitation of academic inventions and for the establishment of research collaborations. She has been also active for the Swiss federal initiative Alliance (alliance-tt.ch) which is aimed at facilitating the search and identification of academic and clinical partners potentially able to address expressed needs from local SMEs. Then, she joined ABCDx in 2016 to contribute to building new partnerships, developing ABCDx’s alliances and bringing in-house projects to future developments in ABCDx.